| Tenascin-C drives persistence of organ fibrosis S Bhattacharyya, W Wang, L Morales-Nebreda, G Feng, M Wu, X Zhou, ... Nature communications 7 (1), 11703, 2016 | 245 | 2016 |
| Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker? K Lakota, J Wei, M Carns, M Hinchcliff, J Lee, ML Whitfield, S Sodin-Semrl, ... Arthritis research & therapy 14, 1-6, 2012 | 115 | 2012 |
| Olive leaf extract attenuates inflammatory activation and DNA damage in human arterial endothelial cells B Burja, T Kuret, T Janko, D Topalović, L Živković, K Mrak-Poljšak, ... Frontiers in cardiovascular medicine 6, 442933, 2019 | 95 | 2019 |
| Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target RG Marangoni, Y Masui, F Fang, B Korman, G Lord, J Lee, K Lakota, ... Scientific reports 7 (1), 4397, 2017 | 77 | 2017 |
| Antiphospholipid antibodies as non-traditional risk factors in atherosclerosis based cardiovascular diseases without overt autoimmunity. A critical updated review A Artenjak, K Lakota, M Frank, S Čučnik, B Rozman, B Božič, Y Shoenfeld, ... Autoimmunity reviews 11 (12), 873-882, 2012 | 69 | 2012 |
| An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis T Yamashita, K Lakota, T Taniguchi, A Yoshizaki, S Sato, W Hong, X Zhou, ... Scientific reports 8 (1), 11843, 2018 | 44 | 2018 |
| Titanium dioxide nanotube arrays for cardiovascular stent applications I Junkar, M Kulkarni, M Bencina, J Kovac, K Mrak-Poljšak, K Lakota, ... ACS omega 5 (13), 7280-7289, 2020 | 43 | 2020 |
| Serum amyloid A is a marker for pulmonary involvement in systemic sclerosis K Lakota, M Carns, S Podlusky, K Mrak-Poljsak, M Hinchcliff, J Lee, ... PloS one 10 (1), e0110820, 2015 | 41 | 2015 |
| The importance of antibacterial surfaces in biomedical applications M Benčina, T Mavrič, I Junkar, A Bajt, A Krajnović, K Lakota, P Žigon, ... Advances in biomembranes and lipid self-assembly 28, 115-165, 2018 | 40 | 2018 |
| Utility of serological biomarkers for giant cell arteritis in a large cohort of treatment-naïve patients B Burja, J Feichtinger, K Lakota, GG Thallinger, S Sodin-Semrl, T Kuret, ... Clinical rheumatology 38, 317-329, 2019 | 37 | 2019 |
| International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by … K Lakota, GG Thallinger, S Sodin-Semrl, B Rozman, A Ambrozic, ... Arthritis research & therapy 14, 1-8, 2012 | 35 | 2012 |
| Serum amyloid A activation of human coronary artery endothelial cells exhibits a neutrophil promoting molecular profile K Lakota, K Mrak-Poljsak, B Bozic, M Tomsic, S Sodin-Semrl Microvascular research 90, 55-63, 2013 | 34 | 2013 |
| Comparison and evaluation of different methodologies and tests for detection of antidsdna antibodies on 889 Slovenian patients’ and blood donors’ sera P Žigon, K Lakota, S Čučnik, T Švec, A Ambrožič, S Sodin-Šemrl, ... Croatian medical journal 52 (6), 694-702, 2011 | 33 | 2011 |
| Serum amyloid A activation of inflammatory and adhesion molecules in human coronary artery and umbilical vein endothelial cells K Lakota, K Mrak-Poljšak, B Rozman, T Kveder, M Tomšič, S Sodin-Semrl European Journal of Inflammation 5 (2), 73-81, 2007 | 32 | 2007 |
| Insight into inflammatory cell and cytokine profiles in adult IgA vasculitis T Kuret, K Lakota, P Žigon, M Ogrič, S Sodin-Šemrl, S Čučnik, M Tomšič, ... Clinical Rheumatology 38, 331-338, 2019 | 30 | 2019 |
| Could antibodies against serum amyloid A function as physiological regulators in humans? K Lakota, GG Thallinger, S Cucnik, B Bozic, K Mrak-Poljsak, A Ambrozic, ... Autoimmunity 44 (2), 149-158, 2011 | 29 | 2011 |
| Increased responsiveness of human coronary artery endothelial cells in inflammation and coagulation K Lakota, K Mrak-Poljsak, B Rozman, S Sodin-Semrl Mediators of inflammation 2009, 2009 | 28 | 2009 |
| COVID-19 in association with development, course, and treatment of systemic autoimmune rheumatic diseases K Lakota, K Perdan-Pirkmajer, A Hočevar, S Sodin-Semrl, Ž Rotar, ... Frontiers in immunology 11, 611318, 2021 | 27 | 2021 |
| A concise review of significantly modified serological biomarkers in giant cell arteritis, as detected by different methods B Burja, T Kuret, S Sodin-Semrl, K Lakota, Ž Rotar, R Ješe, ... Autoimmunity reviews 17 (2), 188-194, 2018 | 26 | 2018 |
| Uropathogenic Escherichia coli induces serum amyloid a in mice following urinary tract and systemic inoculation A Erman, K Lakota, K Mrak-Poljsak, MG Blango, V Krizan-Hergouth, ... PLoS One 7 (3), e32933, 2012 | 26 | 2012 |
